TSANZ SIG Orals: Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease (OLIV) 1
Tracks
TSANZ Orals
| Saturday, March 22, 2025 |
| 11:00 AM - 12:30 PM |
Speaker
Miss Jennie Charoenphannathon
PhD Student
Monash University
Evaluation of the anti-fibrotic effects of bone marrow mesenchymal stem cell-derived extracellular vesicles in IPF patient-derived fibroblasts and bleomycin-injured mice
11:00 AM - 11:15 AM
Prof Anne Holland
Head Of Respiratory Research
Monash University / Alfred Health
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised sham-controlled trial.
11:15 AM - 11:30 AM
Doris Lan
Phd Student
The University Of Sydney
Impact of long-term low-level air pollution exposure on mortality and disease progression in interstitial lung disease patients
11:30 AM - 11:45 AM
Dr Wenying Lu
Research Fellow
University of Tasmania
Patients with idiopathic pulmonary fibrosis have fatty lungs: implications for respiratory physiology
11:45 AM - 12:00 PM
Dr Behdad Shaarbaf Ebrahimi
Research Fellow
University of Auckland
Predicting Pulmonary Hemodynamics and Vascular resistance in CTEPH Patients Using Pre- and Post-Surgical CTPA Data
12:00 PM - 12:15 PM
